Navigation Links
Club cells are 'bad guys' during flu infection
Date:8/18/2014

A specialized subset of lung cells can shake flu infection, yet they remain stamped with an inflammatory gene signature that wreaks havoc in the lung, according to a study published in The Journal of Experimental Medicine.

Seasonal flu is caused by influenza virus, which can infect a variety of cell types in the lung. Infected cells are typically destroyed by the virus itself or by immune cells that attack infected cells. The resulting inflammation can linger on long after the virus has been eliminated leading to persistent symptoms and, in some cases, severe tissue damage.

Club cells are specialized cells that normally protect against inhaled microbes and pollutants. However, researchers from the Icahn School of Medicine at Mount Sinai in New York show that club cells are bad guys during flu infection. Although they are able to rid themselves of the flu virus, club cells fail to switch off expression of inflammatory genes causing prolonged pathology in the lungs even after the virus has been contained. Depletion of surviving club cells lessened destructive lung damage in flu-infected mice.

The authors confirm that human club cells show a similar inflammatory response to flu infection, so targeting club cells might be a strategy to shorten the duration of flu symptoms in humans.


'/>"/>
Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert  

Page: 1

Related medicine news :

1. Researchers identify a mechanism that stops progression of abnormal cells into cancer
2. How breast cancer usurps the powers of mammary stem cells
3. Scientists Inch Closer Toward Using Stem Cells for Spinal Injuries
4. Stem cells show promise for stroke in pilot study
5. Growing human GI cells may lead to personalized treatments
6. Weakness of leukemic stem cells discovered
7. Weakness of leukaemic stem cells discovered
8. Most Cosmetic Procedures Based on Stem Cells Are Bogus, Experts Say
9. Molecular gate that could keep cancer cells locked up
10. Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi
11. A new way to generate insulin-producing cells in Type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Club cells are 'bad guys' during flu infection
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: